Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity
Open Access
- 1 June 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (23), 15390-15399
- https://doi.org/10.1074/jbc.m808331200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemiaJournal of Neuroscience Research, 2008
- The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectinJCI Insight, 2008
- Tissue Transglutaminase Regulates Focal Adhesion Kinase/AKT Activation by Modulating PTEN Expression in Pancreatic Cancer CellsClinical Cancer Research, 2008
- Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancerGynecologic Oncology, 2007
- Platelet-activating Factor Mediates MMP-2 Expression and Activation via Phosphorylation of cAMP-response Element-binding Protein and Contributes to Melanoma MetastasisPublished by Elsevier BV ,2006
- The biological role and regulation of matrix metalloproteinases (MMP) in cancer.2004
- PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.2003
- The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.2002
- The AP-1 site and MMP gene regulation: What is all the fuss about?Matrix Biology, 1997
- Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts.Molecular and Cellular Biology, 1994